This small-cap stock is expected to take off — if its weight-loss pill trial succeeds
Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.
“She wants to join my son at his private liberal-arts college that costs $83,000 a year.”
Management has adapted well to the new normal of the operating and consumer environment and has got back to executing...
Tesla’s stock was headed toward its first gain in four sessions on Friday, after electric vehicle giant’s chief executive, Elon...
The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement.
Oil futures are on track for weekly gains, taking back some of the ground lost last week as fears of...
The cryptocurrency industry’s spending on Washington lobbying rose to a fresh record last year, while it’s started out 2024 with...